The Department of Veterans Affairs approved a rise in the ceiling of its Oracle health-record contract from $10 billion to about $27 billion on 18 August, Stars and Stripes reported, and its next two medical centres, in Cleveland and Anchorage, go live on 24 October on VA’s own schedule. A ceiling sets the maximum VA may spend under the contract. The House Veterans’ Affairs Committee has subpoenaed Oracle’s executive chairman, Larry Ellison, and the chief executive of Oracle Health, Mike Sicilia.
A Pre-Mortem assumes a plan has failed and works backwards to find out why. The plan here is to replace a legacy record system in use since the 1980s with one commercial product, deployed in waves to roughly 170 medical centres by November 2031. Five fixed questions test it.
The Bet
VA’s bet is that one commercial record system, meant to be shared with the Department of Defense, can replace the legacy one, and that accelerating deployment after a pause is how it gets there. VA told Congress in September 2025 that finishing through 2031 would cost an estimated $37.2 billion, a spokesman said this month. The department also says the two-year pause added at least $1 billion in unexpected costs, and it cites unanticipated complexities for the larger ceiling. The prize is a single record for each veteran. VA signed the original deal with Cerner in 2018, and Oracle acquired Cerner in 2022.
The Assumption
The load-bearing belief is that the vendor would carry the cost of fixing its own system. The contract runs on a time-and-materials basis, so each piece of work is negotiated under the ceiling. In 2022 Sicilia told senators Oracle would fix performance and workflow problems at its own expense, Nextgov reported. At the 2 September hearing, Deputy Secretary Paul Lawrence said he had to establish what was promised and how VA’s acquisition team had treated it. The committee heard no detailed account from VA of what drove the extra $17 billion.
The Sequence
Credit is due for the restart. VA paused most deployments in April 2023, resumed in April 2026 with four Michigan hospitals, and publishes site names and dates through 2027. Eleven sites have gone live this year, and 26 more are scheduled for 2027. Then the order of events turns awkward. The ceiling was raised on 18 August, and committee members said the increase caught them off guard, although VA says it gave Congress the estimated total last year. The hearing that tested the increase came two weeks later. Oracle had accepted an invitation to testify and then declined.
The Pager
Pick one veteran with a referral booked at Cleveland the week after go-live. Who tells them the system is safe, and by what measure? VA says it tracks fifteen “return to normal” measures after each go-live, including emergency department throughput, surgeries and inpatient care, and that trouble tickets fall with each deployment. At the same hearing a House Democrat raised reports that about 300 dermatology referrals, some for patients with cancer diagnoses, were cancelled after a go-live. VA’s chief medical officer asked for the details so the department could investigate.
The Proof
The record will fill in quickly. Sicilia is due to testify on 19 November and Ellison on 10 December, according to the subpoenas. The Government Accountability Office says VA has not provided a cost estimate or detailed schedule documentation, so GAO cannot judge the schedule against good practice, and that 14 of its 18 recommendations, including all 12 priority ones, were not fully implemented as of August. Three tests are measurable: whether VA delivers a costed schedule, whether it publishes site-level results against its fifteen measures, and whether GAO’s priority recommendations close. Eighteen months, to April 2028, covers every 2027 wave.
Verdict
If VA delivers a costed schedule, publishes site-level results and closes GAO’s priority recommendations by April 2028, then the $27 billion ceiling bought a rollout that earned its pace, and other health systems can borrow the model. If the 26 sites of 2027 go live without them, then the ceiling bought speed and not proof, and the next cohort of veterans becomes the evidence. Any health system that puts one commercial record at the centre of national care owes its patients the same published test.